{"id":92014,"date":"2026-05-20T16:01:23","date_gmt":"2026-05-20T10:31:23","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=92014"},"modified":"2026-05-20T16:01:25","modified_gmt":"2026-05-20T10:31:25","slug":"anthem-biosciences-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/","title":{"rendered":"Anthem Biosciences Q4 FY26 Results: PAT Rs 189.8 Cr"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/anthem\/anthem-biosciences-ltd-share-price-today\">Anthem Biosciences<\/a> Q4 FY26<\/strong> results were declared on May 19, 2026. Anthem Biosciences reported PAT of Rs 189.8 crore for the quarter ended March 31, 2026, on revenue of Rs 610.9 crore for the quarter ended March 31, 2026. Anthem Biosciences is a CRDMO Pharma company listed on Indian stock exchanges. This article covers the complete Anthem Biosciences Q4 FY26 financial highlights, key performance factors, and FY27 outlook for investors tracking Anthem Biosciences.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\">Click Here \u2013 Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#Anthem_Biosciences_Q4_FY26_Financial_Highlights\" title=\"Anthem Biosciences Q4 FY26 Financial Highlights\">Anthem Biosciences Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#Anthem_Biosciences_Q4_FY26_Performance_Analysis\" title=\"Anthem Biosciences Q4 FY26 Performance Analysis\">Anthem Biosciences Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#Key_Business_Factors_for_Anthem_Biosciences_Q4_FY26\" title=\"Key Business Factors for Anthem Biosciences Q4 FY26\">Key Business Factors for Anthem Biosciences Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#Revenue_and_Operational_Performance\" title=\"Revenue and Operational Performance\">Revenue and Operational Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#Profitability_and_Margin_Trends\" title=\"Profitability and Margin Trends\">Profitability and Margin Trends<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#India_Economic_Context_for_Anthem_Biosciences\" title=\"India Economic Context for Anthem Biosciences\">India Economic Context for Anthem Biosciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#FY27_Outlook_and_Growth_Drivers\" title=\"FY27 Outlook and Growth Drivers\">FY27 Outlook and Growth Drivers<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#Frequently_Asked_Questions_on_the_group\" title=\"Frequently Asked Questions on the group\">Frequently Asked Questions on the group<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#What_is_Anthem_Biosciences_Q4_FY26_PAT\" title=\"What is Anthem Biosciences Q4 FY26 PAT?\">What is Anthem Biosciences Q4 FY26 PAT?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#What_is_Anthem_Biosciences_Q4_FY26_revenue\" title=\"What is Anthem Biosciences Q4 FY26 revenue?\">What is Anthem Biosciences Q4 FY26 revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#When_were_Anthem_Biosciences_Q4_FY26_results_announced\" title=\"When were Anthem Biosciences Q4 FY26 results announced?\">When were Anthem Biosciences Q4 FY26 results announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/anthem-biosciences-q4-fy26-results\/#Is_Anthem_Biosciences_a_good_investment_after_Q4_FY26\" title=\"Is Anthem Biosciences a good investment after Q4 FY26?\">Is Anthem Biosciences a good investment after Q4 FY26?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Anthem_Biosciences_Q4_FY26_Financial_Highlights\"><\/span><strong>Anthem Biosciences Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Notes<\/th>\n<\/tr>\n<tr>\n<td><strong>PAT<\/strong><\/td>\n<td>Rs 189.8 crore<\/td>\n<td>for the quarter ended March 31, 2026<\/td>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 610.9 crore<\/td>\n<td>for the quarter ended March 31, 2026<\/td>\n<\/tr>\n<tr>\n<td><strong>Dividend<\/strong><\/td>\n<td>Rs 2\/share<\/td>\n<td>Subject to AGM approval<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Note: FY26 annual revenue Rs 2,124 crore, PAT Rs 591.8 crore. Fully integrated CRDMO.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anthem_Biosciences_Q4_FY26_Performance_Analysis\"><\/span><strong>Anthem Biosciences Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Anthem Biosciences Q4 FY26 results reflect Anthem Biosciences&#8217;s operational performance during the January to March 2026 quarter. The company operates in the CRDMO Pharma space, a sector supported by India&#8217;s strong GDP growth and domestic demand. The Q4 FY26 results demonstrate continued business execution and operational resilience.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\">Screen the best stocks on the Univest Screener.<\/a><\/p>\n<p>Investors tracking Anthem Biosciences Q4 FY26 will focus on FY27 revenue guidance, margin trajectory, and management&#8217;s capital allocation commentary. Track Anthem Biosciences on the Univest Screener for live fundamentals and real-time updates.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_for_Anthem_Biosciences_Q4_FY26\"><\/span><strong>Key Business Factors for Anthem Biosciences Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Operational_Performance\"><\/span><strong>Revenue and Operational Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Anthem Biosciences Q4 FY26 performance reflects the January to March 2026 quarter, historically the year-end quarter with strong order execution and seasonality effects. India&#8217;s macroeconomic environment with GDP growth above 6.5% provided a constructive backdrop for the CRDMO Pharma sector during this period.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_and_Margin_Trends\"><\/span><strong>Profitability and Margin Trends<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>the company PAT of Rs 189.8 crore for the quarter ended March 31, 2026. Sustaining profitability and improving operating margins will be key watchpoints for FY27 performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"India_Economic_Context_for_Anthem_Biosciences\"><\/span><strong>India Economic Context for Anthem Biosciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The January to March 2026 quarter saw strong domestic consumption, fiscal year-end capital expenditure cycles, and government infrastructure spending. The Reserve Bank of India&#8217;s supportive monetary stance and India&#8217;s resilient growth trajectory provided a stable environment for listed companies across sectors. For Anthem Biosciences, operating in the CRDMO Pharma space, this macro backdrop supported demand conditions during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Outlook_and_Growth_Drivers\"><\/span><strong>FY27 Outlook and Growth Drivers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Following the listed company results, management commentary on FY27 revenue guidance, capex plans, and order pipeline will be the primary catalysts for investor sentiment. The CRDMO Pharma sector continues to benefit from India&#8217;s structural growth, rising domestic consumption, and government policy support.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_the_group\"><\/span><strong>Frequently Asked Questions on the group<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Anthem_Biosciences_Q4_FY26_PAT\"><\/span><strong>What is Anthem Biosciences Q4 FY26 PAT?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> <strong>the business<\/strong> PAT was PAT of Rs 189.8 crore for the quarter ended March 31, 2026. Results declared May 19, 2026. Verify from NSE\/BSE filings before making investment decisions.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Anthem_Biosciences_Q4_FY26_revenue\"><\/span><strong>What is Anthem Biosciences Q4 FY26 revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> the firm revenue from operations was Rs 610.9 crore for the quarter ended March 31, 2026. Check the Univest Screener for live data.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Anthem_Biosciences_Q4_FY26_results_announced\"><\/span><strong>When were Anthem Biosciences Q4 FY26 results announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> the company results were announced on May 19, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Anthem_Biosciences_a_good_investment_after_Q4_FY26\"><\/span><strong>Is Anthem Biosciences a good investment after Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> Investment decisions require individual assessment of fundamentals, valuation, risk tolerance, and investment horizon. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Anthem Biosciences Q4 FY26 results May 19 2026. PAT of Rs 189.8 crore for the quarter ended March 31, 2026. Revenue Rs 610.9 crore. Full analysis.<\/p>\n","protected":false},"author":28,"featured_media":93093,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3858],"class_list":["post-92014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779273095:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_title":["Anthem Biosciences Q4 FY26: PAT Rs 189.8 Cr"],"rank_math_description":["Anthem Biosciences Q4 FY26 results May 19 2026. PAT of Rs 189.8 crore for the quarter ended March 31, 2026. Revenue Rs 610.9 crore. Full analysis."],"rank_math_focus_keyword":["Anthem Biosciences Q4"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["93093"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["12524"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/20160101\/Anthem-Biosciences-Q4-FY26-Results-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/92014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=92014"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/92014\/revisions"}],"predecessor-version":[{"id":93095,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/92014\/revisions\/93095"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/93093"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=92014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=92014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=92014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}